2023 Volume 60 Issue 3 Pages 170-172
I was the first president of the Japanese Society of Pediatric Hematology and Oncology (JSPHO), between 2012 and 2014. During this period, all JSPHO board members made a concerted effort regarding financial reconstruction and office relocation, the introduction of a specialist education system to provide more appropriate medicine for hematology and oncology patients throughout Japan, the promotion of physician-initiated clinical studies regarding childhood cancer together with JCCG, collaboration studies with other Asian countries for globalization, the promotion of the study of fetal and adolescent and young adult (AYA) medicine, and the construction of a system of long-term follow-up for cancer survivors.
Despite several unfinished themes, we believe most were successfully achieved during my tenure.
